The viral capping enzyme nsP1: a novel target for the inhibition of chikungunya virus infection-Reference-Cited by-同舟云学术

The viral capping enzyme nsP1: a novel target for the inhibition of chikungunya virus infection

Published:2016-08 Issue:1 Volume:6 Page:
ISSN:2045-2322
Container-title:Scientific Reports
language:en
Short-container-title:Sci Rep

Author:

Delang L.,Li C.,Tas A.,Quérat G.,Albulescu I. C.,De Burghgraeve T.,Guerrero N. A. Segura,Gigante A.,Piorkowski G.,Decroly E.,Jochmans D.,Canard B.,Snijder E. J.,Pérez-Pérez M. J.,van Hemert M. J.,Coutard B.,Leyssen P.,Neyts J.

Publisher

Springer Science and Business Media LLC

Subject

Multidisciplinary

Link

http://www.nature.com/articles/srep31819.pdf

Reference34 articles.

1. Powers, A. M. et al. Evolutionary relationships and systematics of the alphaviruses. J. Virol. 75, 10118–10131 (2001).

2. Chen, L. H. & Wilson, M. E. Dengue and chikungunya in travelers. Current Opinion in Infectious Diseases 25, 523–529 (2012).

3. Tilston, N., Skelly, C. & Weinstein, P. Pan-European Chikungunya surveillance: designing risk stratified surveillance zones. Int. J. Health Geogr. 8, 61 (2009).

4. Leparc-Goffart, I., Nougairede, A., Cassadou, S., Prat, C. & De Lamballerie, X. Chikungunya in the Americas. The Lancet 383, 514 (2014).

5. Hoz, J. M. D. La et al. Fatal cases of Chikungunya virus infection in Colombia: Diagnostic and treatment challenges. J. Clin. Virol. 69, 27–29 (2015).

Cited by 90 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Preclinical in vivo assessment of the activity of AZD7442 anti-SARS-CoV-2 monoclonal antibodies against Omicron sublineages;Biomedicine & Pharmacotherapy;2024-08

2. Advances in the Development of Non-Structural Protein 1 (NsP1) Inhibitors for the Treatment of Chikungunya Virus Infection;Mini-Reviews in Medicinal Chemistry;2024-06-20

3. Drugs targeting structural and nonstructural proteins of the chikungunya virus: A review;International Journal of Biological Macromolecules;2024-03

4. Repurposed drugs in combinations exert additive anti-chikungunya virus activity: an in-vitro study;Virology Journal;2024-01-04

5. Design, synthesis, and lead optimization of piperazinyl-pyrimidine analogues as potent small molecules targeting the viral capping machinery of Chikungunya virus;European Journal of Medicinal Chemistry;2024-01